The effect of Goreisan for prevention of chronic subdural hematoma recurrence -multicenter study-

The effect of Goreisan for prevention of chronic subdural hematoma recurrence -multicenter study- - The effect of Goreisan for prevention of chronic subdural hematoma recurrence -multicenter study-

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015970

Enrollment

200

Registered

2014-12-16

Start date

2014-12-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic subdural hematoma

Interventions

Administration of Goreisan No administration of Goreisan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patient diagnosed as chronic subdural hematoma 2.Patient performed the operation of drainage 3.Patient aged 60 and over

Exclusion criteria

Exclusion criteria: 1.Patient with severe liver or renal disturbance

Design outcomes

Primary

Measure	Time frame
Recurrence with symptom	—

Countries

Japan

Contacts

Public ContactNaoya Matsuda

Hirosaki University School of Medocine Neurosurgery

cerebro@cc.hirosaki-u.ac.jp0172-39-5115

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026